影像生物标志物标准化倡议:用于高通量影像表型分析的标准定量放射组学
该倡议分三阶段标准化174个放射组学特征:第一阶段25个团队用数字模体直接计算,第二阶段15个团队用肺癌患者CT按预设流程计算衍生特征,第三阶段用51例软组织肉瘤患者的多模态影像前瞻性验证。最终169个特征被标准化,多数可重复性优良(CT 166个、PET 164个、MRI 164个)。
要点
- 169个放射组学特征已标准化,可用于不同软件间的验证与校准。
- 标准化特征在CT上可重复性优良者166个,PET和MRI各164个。
- 前两阶段共识强或以上者分别占95.1%(463/487)和90.6%(1220/1347)。
核心结论
- 共标准化169个放射组学特征,使不同放射组学软件的验证与校准成为可能。
研究设计与样本
- 三阶段评估:第一阶段25个具独特放射组学软件实现的团队从数字模体直接计算174个基本特征衍生的487个特征,不做额外图像处理。
- 第二阶段15个团队使用肺癌患者CT图像和预设图像处理配置计算1347个衍生特征。
- 共识按模态值匹配频次分类:少于3次为弱,3至5次为中等,6至9次为强,10次及以上为很强。
- 第三阶段用51例软组织肉瘤患者的CT、氟18脱氧葡萄糖PET和T1加权MRI公共数据集前瞻性评估标准化特征的可重复性。
诊断标准与关键数值
- 第一阶段初始弱共识为302个特征中的232个(76.8%),最终迭代仅剩487个中的2个(0.4%)。
- 第二阶段初始弱共识为1075个特征中的703个(65.4%),最终迭代仅剩1347个中的19个(1.4%)。
- 强或以上共识:第一阶段487个中463个(95.1%),第二阶段1347个中1220个(90.6%)。
- 前两阶段共标准化174个特征中的169个。
- 第三阶段169个标准化特征中可优良复现者:CT 166个、PET 164个、MRI 164个。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Radiomic features may quantify characteristics present in medical imaging. However, the lack of standardized definitions and validated reference values have hampered clinical use. Purpose To standardize a set of 174 radiomic features. Materials and Methods Radiomic features were assessed in three phases. In phase I, 487 features were derived from the basic set of 174 features. Twenty-five research teams with unique radiomics software implementations computed feature values directly from a digital phantom, without any additional image processing. In phase II, 15 teams computed values for 1347 derived features using a CT image of a patient with lung cancer and predefined image processing configurations. In both phases, consensus among the teams on the validity of tentative reference values was measured through the frequency of the modal value and classified as follows: less than three matches, weak; three to five matches, moderate; six to nine matches, strong; 10 or more matches, very strong. In the final phase (phase III), a public data set of multimodality images (CT, fluorine 18 fluorodeoxyglucose PET, and T1-weighted MRI) from 51 patients with soft-tissue sarcoma was used to prospectively assess reproducibility of standardized features. Results Consensus on reference values was initially weak for 232 of 302 features (76.8%) at phase I and 703 of 1075 features (65.4%) at phase II. At the final iteration, weak consensus remained for only two of 487 features (0.4%) at phase I and 19 of 1347 features (1.4%) at phase II. Strong or better consensus was achieved for 463 of 487 features (95.1%) at phase I and 1220 of 1347 features (90.6%) at phase II. Overall, 169 of 174 features were standardized in the first two phases. In the final validation phase (phase III), most of the 169 standardized features could be excellently reproduced (166 with CT; 164 with PET; and 164 with MRI). Conclusion A set of 169 radiomics features was standardized, which enabled verification and calibration of different radiomics software. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Kuhl and Truhn in this issue.
引用
- Zwanenburg A, Vallières M, Abdalah MA, et al. The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping. Radiology. 2020. PMID: 32154773. doi:10.1148/radiol.2020191145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。